Advanced Enzyme Technologies Limited has informed the Exchange about Shareholders meeting
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies Limited has notified the stock exchanges about its 36th Annual General Meeting (AGM) scheduled for Wednesday, July 30, 2025 at 10:00 AM IST, to be held via Video Conference (VC) / Other Audio Visual Means (OAVM). The agenda includes adopting the audited standalone and consolidated financial statements for FY ended March 31, 2025, declaring a final dividend of ₹1.20 per equity share (on face value of ₹2 each) for FY24-25, and re-appointing Mr. Mukund Kabra (DIN: 00148294) as a director who retires by rotation. The Record Date for dividend entitlement is July 23, 2025, and dividends would be paid on or after August 1, 2025. Special business items include the appointment of Mr. Shiv Hari Jalan as Secretarial Auditor for five consecutive years (FY 2025-26 to 2029-30) and approval of related party transactions with subsidiary JC Biotech Private Limited for the period October 1, 2025 to September 30, 2026. Remote e-voting via NSDL will be open from July 26, 2025 (9:00 AM) to July 29, 2025 (5:00 PM).
Shareholders as of the July 23, 2025 record date will be eligible for the ₹1.20 final dividend, payable on or after August 1, 2025. Routine agenda items like director re-appointment and auditor appointment are unlikely to materially move the stock, but the related party transaction with JC Biotech Private Limited may attract shareholder attention given its materiality.